• Home
  • Stock
  • Orchid Pharma Fundamental Analysis
  • Orchid Pharma Fundamental Analysis

Orchid Pharma fundamental analysis

ORCHPHARMA

HealthcareMid

841.55

11.80 (1.42%)
Last updated on 7 Nov, 2025 | 15:43 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Orchid Pharma Fundamentals

P/E Ratio

50

P/B Ratio

3.33

Div. Yield

0

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Orchid Pharma Fundamentals is currently trading with a P/E Ratio of 50, compared to the sector average of 36.99. Its P/B Ratio stands at 3.33, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.

Orchid Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Orchid Pharma reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.